Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FX3TU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,312
Award facts
- Contract value 100% obligated
- $12,311.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,311.77 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on October 23, 2025, with completion scheduled for October 24, 2025. This non-competitive, firm fixed-price delivery order represents a single-unit procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary distribution operations for federal medical procurement.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems, with an extensive portfolio of federal medical supply deliveries covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Dupixent (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps, indicating this procurement supports the Defense Health Agency's pharmaceutical supply needs for beneficiary populations within the military healthcare system. The delivery order exemplifies the routine pharmaceutical procurement conducted through DLA's Troop Support Medical platform, which enables flexible sourcing of specialized medical products to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FX3TU?
SPE2DB26FX3TU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FX3TU worth?
The government has obligated $12,312 on SPE2DB26FX3TU.
Is contract SPE2DB26FX3TU an order under another contract?
Yes. SPE2DB26FX3TU is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX3TU competed?
The extent of competition for SPE2DB26FX3TU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award